### ğŸ«€ Cardiology: Acute Myocardial Injury Management (TypeÂ 2 NSTEâ€‘ACS)

#### âœ… True Statements
1. **TypeÂ 2 nonâ€“STâ€‘elevation acute coronary syndrome (NSTEâ€‘ACS)** is caused by a myocardial oxygen **supplyâ€“demand mismatch** resulting from nonthrombotic conditions such as hypotension, severe anemia, or atrial arrhythmia with rapid ventricular response.
2. **Initial management** of a **typeÂ 2 NSTEâ€‘ACS** focuses on **identifying and treating the underlying systemic illness** rather than pursuing immediate coronaryâ€‘specific intervention.
3. **Acute myocardial injury** is defined by a **significant rise and/or fall in cardiac troponin concentration** without ischemic chest discomfort, ischemic electrocardiogram changes, or imaging evidence of myocardial ischemia.
4. **Dual antiplatelet therapy** with **aspirin plus a P2Y12 receptor inhibitor** is appropriate for **typeÂ 1 acute coronary syndrome** caused by plaque rupture but **has no proven benefit** in isolated acute myocardial injury from supplyâ€“demand mismatch.
5. In the **absence of STâ€‘segment elevation or highâ€‘risk features**, emergent **coronary angiography** is **not indicated** when myocardial injury is attributable to a systemic condition such as severe sepsis.
6. Oral **Î²â€‘blocker** therapy is **contraindicated** in the presence of **relative hypotension and tissue hypoperfusion**, as can occur during septic shock.

#### ğŸ’¬ Extra
1. Nonthrombotic triggers for typeÂ 2 NSTEâ€‘ACS include **noncardiac hypotension**, **severe anemia**, and **tachyarrhythmia**.
2. Many patients with typeÂ 2 events have underlying **coronary artery disease**, but the coronary disease is **not the proximate cause** of the myocardial injury.

#### ğŸ”· Tags
#Cardiology #HospitalCare #PatientOver65 #HighValueCare #Type2MI #AcuteMyocardialInjury #Sepsis

#### ğŸ“š Reference
DeFilippisÂ AP, ChapmanÂ AR, MillsÂ NL, etÂ al. Assessment and treatment of patients with typeÂ 2 myocardial infarction and acute nonischemic myocardial injury. *Circulation*. 2019;140:1661â€‘1678. PMID:Â 31416350 doi:10.1161/CIRCULATIONAHA.119.040631

#### ğŸ†” Question ID
CVMCQ24004

#### ğŸ•’ Last Updated
JuneÂ 2025

#### ğŸ“– Related Text  
MKSAPÂ 19: CardiovascularÂ Medicine â€” CoronaryÂ ArteryÂ Disease, AcuteÂ CoronaryÂ Syndromes, GeneralÂ ConsiderationsÂ forÂ AcuteÂ CoronaryÂ Syndromes

### ğŸ“˜ Related Text Derivations

#### âœ… True Statements
1. **Acute coronary syndrome (ACS)** is a spectrum of acute ischemic disorders caused by inadequate myocardial blood supply.
2. **ACS** comprises **ST-elevation myocardial infarction (STEMI)** and **non-ST-elevation ACS (NSTE-ACS)**.
3. **NSTE-ACS** includes **non-ST-elevation myocardial infarction (NSTEMI)** and **unstable angina**.
4. Serum **cardiac troponin T or I** concentrations rise in both **STEMI** and **NSTEMI**, with levels determined by the extent of myocardial injury and the timing since event onset.
5. **STEMI** results from complete persistent coronary obstruction and causes **ST-segment elevation** on electrocardiogram.
6. **NSTE-ACS** involves incomplete or transient coronary obstruction, typically **without ST-segment elevation**, although **ST-segment depression** is often present.
7. **Unstable angina** is characterized by new or worsening angina, may show ischemic electrocardiogram changes, and does **not** produce elevated **cardiac troponin** levels.
8. **STEMI** diagnosis requires **persistent ST-segment elevation** and **positive troponin**.
9. **NSTEMI** diagnosis requires **positive troponin**, **no ST-segment elevation**, and presence of **ischemic signs or symptoms**.
10. **Unstable angina** lacks both **ST-elevation** and **troponin elevation**, despite **ischemic symptoms**.
11. If **troponin is elevated** but **no ischemic symptoms or signs** are present, consider **nonischemic myocardial injury**.
12. **Myocardial infarction** requires both **troponin elevation** and **evidence of myocardial ischemia**.
13. **Chronic myocardial injury** is defined by **stable troponin elevation** (â‰¤20% variation).
14. **Acute nonischemic myocardial injury** is defined by a **dynamic troponin pattern** in the absence of ischemia.
15. **Type 1 MI** is caused by **plaque rupture or erosion with thrombus** formation.
16. **Type 2 MI** arises from **oxygen supplyâ€“demand imbalance**, commonly triggered by **sepsis**, **arrhythmias**, or **anemia**.
17. **Cardiac death without biomarker availability** is a distinct classification of myocardial injury.

#### ğŸ’¬ Extra
1. Signs of ischemia include **ischemic ECG changes**, **new Q-waves**, **imaging abnormalities**, or **autopsy findings**.
2. Troponin interpretation should consider **timing of presentation** and **serial values**, especially in early or late presenters.
3. Management of STEMI and NSTE-ACS follows structured algorithms.
4. Accurate MI classification relies on integrating **biomarker changes** with **clinical context and diagnostic criteria**.

---

#### ğŸ–¼ï¸ Supplemental Figures

<!--Algorithm for Diagnosis of Acute Coronary Syndromes-->
<figure>
  <img src="Algorithm for Diagnosis of Acute Coronary Syndromes.svg" alt="Algorithm for Diagnosis of Acute Coronary Syndromes" />
  <figcaption>
    <strong>Abbreviations:</strong>  
    NSTE-ACS = nonâ€“ST-elevation acute coronary syndrome;  
    NSTEMI = nonâ€“ST-elevation myocardial infarction;  
    STEMI = ST-elevation myocardial infarction.
  </figcaption>
</figure>

<!--Model for Myocardial Injury Interpretation and Management-->
<figure>
  <img src="Model for Myocardial Injury Interpretation and Management.svg" alt="Model for Myocardial Injury Interpretation and Management" />
  <figcaption>
    Ischemic thresholds vary substantially in relation to the magnitude of the stressor and the extent of underlying cardiac disease.  
    <br><strong>Abbreviations:</strong>  
    CHF = congestive heart failure;  
    MI = myocardial infarction;  
    NSTEMI = nonâ€“ST-elevation myocardial infarction;  
    STEMI = ST-elevation myocardial infarction;  
    URL = upper reference limit.
    <br><br>
    <strong>Footnotes:</strong>  
    <sup>a</sup> Serial troponin assessment, using care in interpretation of values in very early or late presenters given reduced sensitivity of initial values and trends.  
    <br><sup>b</sup> Stable denotes â‰¤20% variation of troponin values in the appropriate clinical context.  
    <br><sup>c</sup> Symptoms or signs of clinical myocardial ischemia, including ischemic ECG changes, new pathologic Q-waves, cardiac imaging abnormalities, or evidence of injury substrate at angiography or autopsy.  
    <br><sup>d</sup> See Figure: Algorithm for Management of STEMI.  
    <br><sup>e</sup> See Figure: Algorithm for Initial Management of NSTE-ACS.  
    <br><br>
    <strong>Source:</strong> Thygesen K, Alpert JS, Jaffe AS, et al; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). <em>J Am Coll Cardiol</em>. 2018;72:2231-2264. PMID: 30153967 doi:<a href="https://doi.org/10.1016/j.jacc.2018.08.1038" target=\"_blank\">10.1016/j.jacc.2018.08.1038</a>.
  </figcaption>
</figure>
